GlassScriptPhysician profile
Lisa M Lowery
NPI 1235119975
$11,706.79
in general payments reported to CMS, 2019-2025
6 companies · $3,042 in 2025
The $3,042 reported for 2025 was more than what 98% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,834 · 2021: $1,375 · 2022: $69.23 · 2023: $1,394 · 2024: $2,993 · 2025: $3,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,376 · Food and Beverage: $52.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,376.04 |
| Food and Beverage | $52.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,803.65 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $2,768.87 | 2019 | |
| Abbvie INC. | $49.73 | 2022 | |
| Ironshore Pharmaceuticals INC. | $47.87 | 2019 | |
| Janssen Biotech, INC. | $19.50 | 2022 | |
| Shire North American Group INC | $17.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lowery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.